Sickle cell microvascular paradox-oxygen supply-demand mismatch

Area of Science:

• Physiology
• Hematology
• Vascular Biology

Background:

• Sickle cell disease (SCD) patients often have normal global oxygen delivery but still experience end-organ damage.
• This suggests potential microvascular dysfunction impacting tissue oxygenation.

Purpose of the Study:

• To investigate microvascular dysregulation and tissue oxygenation in SCD patients.
• To assess the impact of chronic transfusion therapy on these parameters.

Main Methods:

• Fingertip laser Doppler flowmetry and regional oxygen saturation (rSO2) measurements were performed during flow-mediated dilation (FMD) studies.
• 26 chronically transfused SCD, 75 non-transfused SCD, and 18 control subjects were included.

Main Results:

• Non-transfused SCD patients had higher resting perfusion but lower rSO2, indicating resting hypoxia.
• Impaired post-occlusive hyperemia and FMD were observed in SCD patients.
• Transfusion therapy improved FMD and oxygen supply-demand matching but did not improve microcirculatory hyperemia.

Conclusions:

• Non-transfused SCD patients exhibit impaired microvascular function and resting hypoxia despite compensated oxygen delivery.
• Transfusion therapy partially corrects FMD and oxygen supply-demand matching, highlighting its benefits but also limitations in addressing microvascular issues.